Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.mangalamdrugs.com | |
Market Cap | 152.68 Cr. | |
Enterprise Value(EV) | 222.65 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -10.78 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.73 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 87.77 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.10 | Calculated using Price: 96.46 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.58 Cr. | 15,828,248 Shares |
FaceValue | 10 | |
About Mangalam Drugs And Organics Ltd. | ||
Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977. |
1 Day |
|
+0.52% |
1 Week |
|
-0.16% |
1 Month |
|
-4.40% |
3 Month |
|
-8.26% |
6 Month |
|
-6.80% |
1 Year |
|
-32.52% |
2 Year |
|
-22.72% |
5 Year |
|
+32.06% |
10 Year |
|
+2000% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 23.36 | 38.91 | 32.11 | 20.99 | -8.05 | 8.27 | 23.83 | 13.97 | 0.84 | |
Return on Capital Employed (%) | 15.69 | 29.14 | 30.18 | 25.35 | 1.76 | 10.66 | 28.01 | 18.34 | 6.56 | |
Return on Assets (%) | 4.16 | 9.73 | 12.76 | 9.56 | -3.67 | 3.73 | 11.31 | 6.64 | 0.37 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 29 | 62 | 86 | 104 | 96 | 104 | 131 | 151 | 152 | 139 | |
Non Curr. Liab. | 41 | 25 | 26 | 23 | 25 | 17 | 24 | 48 | 42 | 39 | |
Curr. Liab. | 99 | 73 | 78 | 100 | 91 | 109 | 109 | 130 | 165 | 209 | |
Minority Int. | |||||||||||
Equity & Liab. | 170 | 160 | 190 | 227 | 211 | 231 | 264 | 328 | 360 | 387 | |
Non Curr. Assets | 54 | 60 | 94 | 104 | 106 | 111 | 130 | 143 | 153 | 152 | |
Curr. Assets | 116 | 100 | 96 | 123 | 105 | 119 | 134 | 185 | 207 | 235 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 170 | 160 | 190 | 227 | 211 | 231 | 264 | 328 | 360 | 387 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 221 | 295 | 303 | 279 | 228 | 282 | 385 | 451 | 372 | 323 | |
Other Income | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | ||
Total Income | 221 | 295 | 303 | 280 | 228 | 284 | 385 | 451 | 373 | 324 | |
Total Expenditure | -200 | -258 | -257 | -233 | -218 | -259 | -327 | -402 | -347 | -318 | |
PBIDT | 20 | 38 | 46 | 48 | 10 | 25 | 58 | 49 | 26 | 6 | |
Interest | -10 | -9 | -10 | -12 | -9 | -10 | -9 | -11 | -13 | -13 | |
Depreciation | -4 | -4 | -5 | -7 | -7 | -8 | -9 | -10 | -11 | -13 | |
Taxation | 0 | -8 | -9 | -9 | -2 | 2 | -12 | -8 | -1 | 3 | |
Exceptional Items | |||||||||||
PAT | 6 | 16 | 22 | 20 | -8 | 8 | 28 | 20 | 1 | -17 | |
Adjusted EPS | 5 | 11 | 14 | 13 | -5 | 5 | 18 | 12 | 1 | -11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 7 | 14 | 22 | 43 | 25 | 22 | 31 | 28 | 26 | 40 | |
Cash Fr. Inv. | -2 | -4 | -11 | -39 | -16 | -9 | -7 | -31 | -27 | -22 | |
Cash Fr. Finan. | -5 | -10 | -11 | -3 | -9 | -11 | -23 | 3 | 3 | -17 | |
Net Change | 0 | 1 | 0 | 0 | 0 | 1 | 0 | -1 | 1 | 1 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 0 | 1 | 2 | 1 | 2 | 3 |
Fri, 10 Nov 2023
Copy of Newspaper Publication
|
|
Thu, 09 Nov 2023
Outcome of Board Meeting
|
|
Thu, 09 Nov 2023
Financial Result Updates
|
Mon, 04 Dec 2023 |
|
|
|
|
|